Lao People's Democratic Republic vs Yemen: Previously treated cases tested for RR-/MDR-TB
Lao People's Democratic Republic
100.0%
in 2024
Yemen
100.0%
in 2024
Lao People's Democratic Republic rank
1st
Yemen rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Lao People's Democratic Republic
- Yemen
How they compare
Lao People's Democratic Republic currently reports 100.0% against 100.0% in Yemen, a difference of 0.0%.
The two have swapped places 5 times across 12 shared years of data; in 2012 it was Lao People's Democratic Republic ahead.
Lao People's Democratic Republic ranks 1st and Yemen ranks 1st of 180 countries.
Lao People's Democratic Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 44.7% | 23.4% | 21.3% | Lao People's Democratic Republic |
| 2020s | 100.0% | 60.0% | 40.0% | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Lao People's Democratic Republic or Yemen?
- Lao People's Democratic Republic, at 100.0% against 100.0% in Yemen as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Lao People's Democratic Republic and Yemen?
- 0.0%, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Yemen?
- 12 years are reported by both, from 2012 to 2024.
- How do Lao People's Democratic Republic and Yemen rank globally for previously treated cases tested for rr-/mdr-tb?
- Lao People's Democratic Republic ranks 1st and Yemen ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.